| 1 |
33920140 | Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway. | 2021 Apr 10 |
6 |
| 2 |
32828740 | Central nervous system (CNS) tumor cell heterogeneity contributes to differential platinum-based response in an in vitro 2D and 3D cell culture approach. | 2020 Oct |
1 |
| 3 |
33042614 | Mechanisms of resistance in head and neck cancer. | 2020 |
1 |
| 4 |
33076245 | Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression. | 2020 Oct 15 |
3 |
| 5 |
31578574 | Downregulation of MUTYH contributes to cisplatin‑resistance of esophageal squamous cell carcinoma cells by promoting Twist‑mediated EMT. | 2019 Dec |
5 |
| 6 |
29665439 | Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer. | 2018 Jun |
1 |
| 7 |
30066890 | Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT. | 2018 Oct |
1 |
| 8 |
28915582 | MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression. | 2017 Aug 22 |
2 |
| 9 |
25867064 | miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin. | 2016 Jan 21 |
3 |
| 10 |
23280703 | TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin. | 2014 Jun |
4 |
| 11 |
24468065 | miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. | 2014 Jan 27 |
7 |
| 12 |
23426781 | TWIST interacts with endothelin-1/endothelin A receptor signaling in osteosarcoma cell survival against cisplatin. | 2013 Mar |
5 |
| 13 |
24148247 | miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma. | 2013 Nov 15 |
2 |
| 14 |
22245869 | Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells. | 2012 Apr |
3 |
| 15 |
22673193 | Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition. | 2012 Jun 7 |
5 |
| 16 |
21083641 | Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells. | 2011 Jul |
1 |
| 17 |
20491776 | P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance. | 2010 Aug |
1 |
| 18 |
18331824 | Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway. | 2008 May 16 |
5 |
| 19 |
17072341 | Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells. | 2007 May 3 |
1 |